BioXcel Therapeutics Gain (Loss) on Investment Securities (Quarterly) Analysis

BioXcel Therapeutics, Inc. (BTAI)

1.48 -0.13 (-8.07%) USD | NASDAQ | Mar 06, 16:00

1.47 -0.01 (-0.68%) After-Hours: 20:00

View Gain (Loss) on Investment Securities (Quarterly) for BTAI.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Gain (Loss) on Investment Securities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Gain (Loss) on Investment Securities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Gain (Loss) on Investment Securities (Quarterly) Benchmarks

Start Trial

Rigel Pharmaceuticals, Inc.	--
Puma Biotechnology, Inc.	--
Quince Therapeutics, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	Upgrade